Department of Radiology, University of Occupational and Environmental Health School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyusyu 807-8555, Japan.
Radiology. 2012 Sep;264(3):852-8. doi: 10.1148/radiol.12111363. Epub 2012 Jul 6.
To evaluate whether contrast material-enhanced (CE) fast imaging employing steady-state acquisition (FIESTA) can depict the anterior optic pathways in patients with large suprasellar tumors.
Institutional review board approval was obtained. Twenty-eight patients with large suprasellar tumors undergoing surgical treatment (19 pituitary adenomas, six meningiomas, and three additional miscellaneous tumors) underwent preoperative magnetic resonance (MR) imaging, including CE FIESTA, at 3.0 T. Two radiologists assessed the visibility of five segments of the optic pathways (bilateral optic nerves and optic tracts, optic chiasm) with CE FIESTA and conventional MR imaging, including thin-section coronal T2-weighted imaging and CE T1-weighted imaging, by using a three-point scale. Moreover, the preoperative signal intensity of the optic pathways was correlated with pre- and postoperative visual impairment to determine whether high signal intensity at CE FIESTA is predictive of persistence of visual impairment after surgery. The χ(2) test was used to compare scores assigned to CE FIESTA and conventional MR images.
The percentage of anterior optic pathways rated as visible was significantly higher with CE FIESTA than with conventional MR imaging (100% [140 of 140 segments] vs 78% [109 of 140 segments], P < .05). Thirty-one of the 140 segments (22%) were not depicted with conventional MR imaging; all of these 31 segments were visualized with CE FIESTA. For 12 patients who underwent transcranial surgery, the anatomic locations of the optic pathways at CE FIESTA were compatible with the surgical findings. CE FIESTA helped predict persistent visual impairment after surgical treatment with a sensitivity of 75% (three of four patients) and a specificity of 96% (23 of 24 patients). The accuracy of CT FIESTA in the prediction of visual loss was significantly higher than that of T2-weighted imaging (93% [26 of 28 patients] vs 50% [14 of 28 patients], P < .05).
CE FIESTA is useful for the preoperative localization of the anterior optic pathways in patients with large suprasellar tumors and offers the potential to predict persistent visual impairment after decompression.
评估对比增强快速稳态采集(CE FIESTA)是否能显示大型鞍上肿瘤患者的前视神经通路。
本研究获得机构审查委员会批准。28 例接受手术治疗的大型鞍上肿瘤患者(19 例垂体腺瘤、6 例脑膜瘤和 3 例其他肿瘤)在 3.0T 磁共振成像(MR)设备上进行术前检查,包括 CE FIESTA。两位放射科医生使用三点评分法评估 CE FIESTA 和常规 MR 成像(包括薄层冠状 T2 加权成像和 CE T1 加权成像)对 5 段视神经通路(双侧视神经和视束、视交叉)的显示情况。此外,还将术前视神经通路的信号强度与术前和术后视力障碍相关联,以确定 CE FIESTA 中的高信号强度是否能预测术后视力障碍的持续存在。采用 χ²检验比较 CE FIESTA 和常规 MR 图像的评分。
CE FIESTA 对前视神经通路的显示率明显高于常规 MR 成像(100%[140/140 段]比 78%[109/140 段],P<.05)。31 个(22%)段在常规 MR 成像上不能显示,这些段在 CE FIESTA 上均可见。在 12 例行经颅手术的患者中,CE FIESTA 上视神经通路的解剖位置与手术结果相符。CE FIESTA 有助于预测手术治疗后持续的视力障碍,其灵敏度为 75%(4 例中的 3 例),特异性为 96%(24 例中的 23 例)。CE FIESTA 在预测视力丧失方面的准确性明显高于 T2 加权成像(93%[28 例中的 26 例]比 50%[28 例中的 14 例],P<.05)。
CE FIESTA 可用于显示大型鞍上肿瘤患者的前视神经通路,有助于预测减压术后的持续视力障碍。